Abbott logo — Life-changing health technologies in the area of diagnostics...

Abbott

Life-changing health technologies in the area of diagnostics, medical devices, nutritionals and branded generic medicines

Founded 1944 United States United States 152119 employees IPO Total: $6.80M Biotechnology, Health Care +4

General Information

Company Name Abbott
Founded Year 1944
Location United States United States +1
Employees 152119
Industries Biotechnology, Health Care, Manufacturing +3
Funding Stage IPO

Get notified when Abbott moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Product Launch Aug 31, 2026

Abbott has launched its new Similac 360 Total Care Made With Whole Milk, the first ready-to-feed infant formula made with whole milk in the U.S.

Market Expansion Aug 28, 2026

Abbott has announced market expansion for its Amulet™ 360 Left Atrial Appendage Occluder into Europe.

New Partnership Aug 26, 2026

Abbott has partnered with the Big Ten Conference to host the "We Give Blood" competition, encouraging blood donations through December 4.

Regulatory Approval Aug 25, 2026

Abbott's Libre Duo 10 Day system has received U.S. FDA authorization.

Growth Metrics Aug 12, 2026

Abbott helped save 250,000 lives last year through blood donation initiatives, addressing the blood shortage.

About Abbott

Abbott is a distinguished global leader in the healthcare sector, renowned for its suite of life-changing health technologies. Founded in 1944, the company has solidified its presence across multiple industries, including Biotechnology, Health Care, Manufacturing, Medical Devices, Nutrition, and Pharmaceuticals.

With its headquarters in the United States, Abbott commands a broad geographical footprint, delivering innovative healthcare solutions to consumers in over 160 countries. Their impressive talent pool, comprising 122,000 colleagues, ensures a dynamic and adaptable workforce.

In terms of investment, Abbott received their last known funding—an infusion of $100.00K in Post IPO Debt—on 01 March 2011. Despite the time since its last funding, the company's longstanding history and multifaceted industry involvement highlight its potential stability and continuous innovations, positioning it as a lucrative prospect for investors seeking a stronghold in the healthcare space.

Taxonomy: Diagnostics, Nutritional Products, Branded Generic Medicines, Pharmaceuticals, HIV Treatment, Thyroid Hormone Therapy, Anticonvulsant Drugs, Autoimmune Disease Therapy, Global Operations, Diversity and Inclusion, Blood Screening Technology, Rheumatoid Arthritis Therapy, Healthcare Innovation

Services & Products

Diagnostics Testing
Diabetes Management Solutions
Cardiovascular Health Products
Biowearable Technology
Nutritional Products
Pharmaceutical Solutions

Target Customers

Healthcare Professionals Patients with Diabetes Cardiovascular Patients Individuals Focused on Nutrition Medical Diagnostics Labs Early Career Professionals

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post Ipo Debt •••••• - 01 Mar 2011
Post Ipo Debt •••••• - 01 Mar 2009
IPO •••••• - 01 Dec 1980

Abbott Alternatives & Competitors

View All Alternatives
Abbott vs
Abbott
Abbott United States

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our po...

133237 employees
Abbott vs
Abbott Foods
Abbott Foods United States

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our po...

1 employees
Biotechnology, Health Care
Abbott vs
Exact Sciences
Exact Sciences United States

Changing the way we think about detecting and treating cancer.

Acquired
5326 employees
Biotechnology

FAQ About Abbott

Life-changing health technologies in the area of diagnostics, medical devices, nutritionals and branded generic medicines
Abbott was founded in 1944.
Abbott is headquartered in United States.
Abbott operates in the following industries: Biotechnology, Health Care, Manufacturing, Medical Devices, Nutrition, Pharmaceutical.
Abbott has approximately 152119 employees.
Abbott has completed 3 funding rounds, raising a total of $6.80M. The latest funding stage is IPO.
Abbott offers: Diagnostics Testing, Diabetes Management Solutions, Cardiovascular Health Products, Biowearable Technology, Nutritional Products, Pharmaceutical Solutions.
Top alternatives and competitors to Abbott include Abbott, Abbott Foods, Exact Sciences, Alere Inc., AIDS Healthcare Foundation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Abbott and Abbott are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Abbott and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy